DENVER, NC / February 5, 2019 / CVR Medical Corp. (CVM.V) (TSXV: CVM) (OTCQB: CRRVF) (“CVR Medical”) a Canadian listed and US based healthcare company in the medical device sector announces that James D’Orta. M.D. has joined the Board of Directors. Dr. D’Orta joins CVR Medical’s extensive leadership as the company moves toward market entry of its disruptive medical device, the Carotid Stenotic Scan (CSS).
Dr. D’Orta is a seasoned business executive, entrepreneur, and physician, with many years of leadership experience in both clinical and business settings. Dr. D’Orta is known for his strategic insights and contributions on numerous boards of directors in both the profit and nonprofit sectors; his ability to position new and existing companies for long-term success; and his extensive national and international network of senior-level contacts in business, government, and nonprofits.
Dr. D’Orta currently services on the Board of Directors of Accuity Delivery Systems, an emerging company that helps hospital systems reduce risk and improve financial performance through better clinical documentation, inpatient coding, business intelligence and technology. Previously, he served as a Director of Cogentix Medical (NASDAQ: CGNT), a medical device company that designs, develops, manufactures and markets technologies for the urology and gynecology markets. As a member of the Governance and Audit committees and Chairman of the Compensation Committee, he helped oversee a broadening of the company’s tech portfolio and its acquisition by LABORIE Medical Technologies. Before that, he was Acting CEO of ACell, a Maryland-based medical device manufacturer. Prior to becoming CEO, he served as a member of the Board of Directors and as chairman of the board’s Corporate Governance, Nominating and Compliance Committees. Prior to ACell, Dr. D’Orta served as the Founder and CEO of Consumer Health Services, Inc., which provided medical support for the walk-in medical clinics in Duane Reed drugstores. Consumer Health Services was acquired by Walgreens in 2013. He formerly was an investor, medical advisor and member of the Board of Directors of Minute Clinic, the walk-in medical clinics which was sold to CVS drugstores. Earlier, he was founder and CEO of LifeLink MD, providing distribution, training and medical oversight for automated external defibrillators (AEDs), as well as public advocacy and education that helped make AEDS widely available. That company was later sold to Medtronic. In the 1980s, he was a partner in Professional Emergency Physicians (PEP), a group of emergency medical physicians with contracts in several leading hospitals in the DC-Maryland-Virginia region. PEP was later merged into Sterling Health, Inc.
About CVR Medical
CVR Medical Corp. is a healthcare company that operates in the medical device industry focused on the commercialization of its disruptive, proprietary Carotid Stenotic Scan (CSS). The CSS device is a diagnostic tool that encompasses subsonic, infrasonic, and low frequency sound wave analysis technology. The CSS is a patented device designed to detect and measure carotid arterial stenosis. CVR is currently in pivotal clinical trials in preparation for its planned submission to the FDA. CVR is led by an experienced and proven team of professionals with extensive healthcare, medical device, international expansion, regulatory and sales experience. CVR Medical trades on the TSX Venture Exchange under the symbol CVM. Additional information regarding the Company can be found in our recent filings with the SEDAR as well as the information maintained on our website at www.cvrmed.com
ON BEHALF OF THE BOARD:
(signed) “Peter Bakema”
CEO, President & Director
Peter Bakema, CEO, President and Director
Email: info@cvrmed.com
or
Marc S. Lubow, Executive Vice President
Email: marclubow@cvrmed.com